Clinica Chimica Acta:弗里德瓦尔德公式计算的非空腹LDL-C水平与中国冠心病患者每日早餐后直接测量的LDL-C水平比较

2019-09-22 gladiator MedSci原创

<span lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size: 14.0pt;font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:宋体; mso-bidi-font-family:&quot;Times New Roman&qu

LDL-C水平可以用直接法(LDL-CM)测定,也可以用弗里德瓦尔德公式(LDL-CC)计算。本研究旨在探讨中国冠心病(CHD)患者早餐后LDL-CMLDL-CC的差异。

本研究共纳入住院患者330例,其中203例为冠心病患者(冠心病组)100例为非冠心病对照组(CON)。血清血脂水平的参数,包括LDL-CCLDL-CM, 0, 24h (h)监控每天早餐后在所有项目。

在每组在禁食状态和在冠心病组餐后4hLDL-CM明显高于LDL-CC(P<. 05)。每组餐后LDL-CMLDL-CC显著减少(P<. 05)。餐后LDL-CM下降明显比LDL-CC (P<. 05)。对冠心病患者在入院前服用他汀类药物1 月以上,非禁食LDL-CMLDL-CC百分比明显高于空腹值,特别是在4h (P<. 05)4h时的LDL-CM的百分比偏差明显不同于其禁食值。然而,禁食和非禁食之间没有显著差异百分比偏差。

本研究结果说明临床对冠心病患者非空腹LDL-C水平的监测可能比较复杂,对其的判断可能不仅取决于获取LDL-C水平的方法,还取决于评价方法。

原始出处:

Qiu-zhen LinYan-qiao ChenComparison of non-fasting LDL-C levels calculated by Friedewald formula with those directly measured in Chinese patients with coronary heart disease after a daily breakfast

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849748, encodeId=b3b01849e485a, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 01 01:56:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422580, encodeId=325014225809a, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447758, encodeId=cf22144e758c3, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601620, encodeId=6256160162003, content=<a href='/topic/show?id=23ce5951642' target=_blank style='color:#2F92EE;'>#早餐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59516, encryptionId=23ce5951642, topicName=早餐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=767c18890183, createdName=LSJ117, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=)]
    2019-11-01 windight
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849748, encodeId=b3b01849e485a, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 01 01:56:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422580, encodeId=325014225809a, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447758, encodeId=cf22144e758c3, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601620, encodeId=6256160162003, content=<a href='/topic/show?id=23ce5951642' target=_blank style='color:#2F92EE;'>#早餐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59516, encryptionId=23ce5951642, topicName=早餐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=767c18890183, createdName=LSJ117, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=)]
    2019-09-24 zhwj
  3. [GetPortalCommentsPageByObjectIdResponse(id=1849748, encodeId=b3b01849e485a, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 01 01:56:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422580, encodeId=325014225809a, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447758, encodeId=cf22144e758c3, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601620, encodeId=6256160162003, content=<a href='/topic/show?id=23ce5951642' target=_blank style='color:#2F92EE;'>#早餐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59516, encryptionId=23ce5951642, topicName=早餐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=767c18890183, createdName=LSJ117, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1849748, encodeId=b3b01849e485a, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 01 01:56:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422580, encodeId=325014225809a, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447758, encodeId=cf22144e758c3, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601620, encodeId=6256160162003, content=<a href='/topic/show?id=23ce5951642' target=_blank style='color:#2F92EE;'>#早餐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59516, encryptionId=23ce5951642, topicName=早餐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=767c18890183, createdName=LSJ117, createdTime=Tue Sep 24 07:56:00 CST 2019, time=2019-09-24, status=1, ipAttribution=)]
    2019-09-24 LSJ117